JPMorgan Chase & Co.’s health-care bankers in the past year worked on the $74 billion takeover of Celgene Corp. and the $62 billion sale of Shire PLC.
Last fall they pitched Cianna Medical, a California company with tumor-detecting technology and about $40 million in annual revenue, on a sale. “I kept saying, tell me again why you’re interested in this deal?” said Jill Anderson, Cianna’s then-chief executive.
Major economies are nearing recession territory, we can help you make decisions that will help you prosper over the long run contact us today!
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Tesla’s biggest supporters on Wall Street are nervous about the company's first quarter resultsEven the staunchest of bulls are worried about Tesla's results this quarter.
続きを読む »